Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
Mefloquine inhibits cholinesterases at the mouse neuromuscular junction.
复制标题
甲氟喹抑制小鼠神经肌肉接头处的胆碱酯酶。
DOI:
10.1016/j.neuropharm.2005.06.011
复制
发表时间:
2005
影响因子:
4.7
通讯作者:
Hognason,Kormakur
中科院分区:
文献类型:
--
作者:
McArdle,JosephJ;Sellin,LawrenceC;Coakley,KathleenM;Potian,JosephG;Quinones-Lopez,MaryC;Rosenfeld,ClintA;Sultatos,LesterG;Hognason,Kormakur
Mefloquine is effective against drug-resistant Plasmodium falciparum. This property, along with its unique pharmacokinetic profile, makes mefloquine a widely prescribed antimalarial drug. However, mefloquine has neurologic effects which offset its therapeutic advantages. Cellular actions underlying mefloquine's neurologic effects are poorly understood. Here, we demonstrate that mefloquine inhibits human recombinant acetylcholinesterase. To explore the consequences of this action, we investigated mefloquine's actions at a model cholinergic synapse, the mouse neuromuscular junction. Sharp electrode recording was used to record miniature endplate potentials (mepps) in the Triangularis sterni muscle. Within 30min of exposure to 10μM mefloquine, mepps were altered in three ways: 10–90% rise time, 90–10% decay time and amplitude significantly increased. Mepp decay time increased linearly with mefloquine concentration. Pretreatment of muscles with the cholinesterase inhibitor physostigmine (3μM) precluded the mefloquine-induced prolongation of mepp decay. Mefloquine also prolonged mepps at endplates of acetylcholinesterase knock-out mice. Since the selective butyrylcholinesterase inhibitor iso-OMPA (100μM) also prolonged mepp decay at the neuromuscular junction of acetylcholinesterase knock-out mice, mefloquine inhibition of this enzyme is physiologically relevant. The non-selective anti-cholinesterase action can contribute to the neurologic effects of mefloquine.